Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05097599
Title Strata PATH (Precision Indications for Approved Therapies) (Strata PATH)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Strata Oncology
Indications

Advanced Solid Tumor

Therapies

Binimetinib + Encorafenib

Trastuzumab deruxtecan

Enfortumab vedotin-ejfv

Talazoparib

Lorlatinib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.